Novatek International is pleased to announce that Pillar5 Pharma Inc. has chosen Nova-LIMS for use at their sterile ophthalmic manufacturing site in Arnprior, Ontario Canada.
Pillar5’s strategic decision to utilize the building block-like components of Novatek’s Product suite for Raw Materials, Finished Product and Stability study management reinforces our mandate for organizations in the life sciences industry to build their solution, with the flexibility to grow at their needs and implement at their pace.
We are pleased to welcome Pillar5 Pharma Inc. to our family of clientele and look forward to supporting their Quality and Data Compliance needs for years to come.
About Pillar5 Pharma Inc.
Pillar5 Pharma Inc. provides access to safe medications, through various partners, as a Contract Manufacturing Organization (CMO) in solid dose tablets/capsules and ophthalmics. Further to the acquisition of the former Pfizer plant, this plant has been in operation since 1956. Specializing in niche product portfolios for human and animal health, we enhance speed to market ensuring patient care with quality products. We work with clients to provide solutions allowing maximum profitably and offer lean manufacturing and production strategies This facility has been successfully inspected by Health Canada in 2013 and the FDA in 2013 (no 483’s).
